Investor · San Francisco, CA
Clare Ozawa
Open Clare in the network graph →Filings
71
SEC Form D
Connections
229
co-filers
Capital
$2.2B
across filings
Active
Nov 2019
to May 2024
Most-connected co-filers (229)
Bradley Bolzon · San Francisco, CA28 sharedThomas Woiwode · San Francisco, CA22 sharedJason Liu · San Diego, CA18 sharedJerel Davis · San Francisco, CA18 sharedAlex Mayweg · San Francisco, CA16 sharedFrancois Ferre · San Diego, CA13 sharedDr. Sankar Das Gupta · Mississauga, Ontario, Canada13 sharedSame Infrastructure Specialist Asset Management Ltd · Melbourne, Victoria, Channel Islands13 sharedPeter Kirsch · Kensington, MD13 sharedTimothy Nolan · Stamford, CT13 sharedDr. Bejoy K. Das Gupta · Mississauga, Ontario, Canada13 sharedAnthony Vinci · Stamford, CT13 sharedQBG Manager LLC · Stamford, CT13 sharedAustin Westerling · Boston, MA13 sharedDr. Carolyn K. Hansson · Mississauga, Ontario, Canada13 sharedRajshekar P. Das Gupta · Mississauga, Ontario, Canada13 sharedRobin N. Praeger · San Francisco, CA12 sharedJorge Garces · San Diego, CA11 sharedMar N. Hershenson · Palo Alto, CA10 sharedPetpiboon J. Prasit · San Francisco, CA9 sharedJerel Davis · Cleveland, OH9 sharedPejman N. Nozad · Palo Alto, CA8 sharedJohn Hanke · San Francisco, CA7 sharedEdouard Saget · SALT LAKE CITY, UT7 shared
Recent filings (71)
858 Therapeutics, Inc.Jul 2024 · 16 co-filers$50.4MLycia Therapeutics, Inc.May 2024 · 13 co-filers$106.6MLycia Therapeutics, Inc.May 2024 · 13 co-filers$106.6MVersant Venture Capital SPV I (SAB), L.P.May 2024 · 22 co-filers$5.0MMarket Wagon, Inc.Sep 2023 · 11 co-filers$4.8MVersant Vantage III, L.P.Apr 2023 · 24 co-filers$298.7MVersant Venture Capital IX, L.P.Apr 2023 · 24 co-filers$600.4MVersant Voyageurs III, L.P.Apr 2023 · 25 co-filers$300.2MLenz Therapeutics, Inc.Mar 2023 · 17 co-filers$83.5MLenz Therapeutics, Inc.Nov 2022 · 13 co-filers$49.0MVersant Venture Capital IX, L.P.Oct 2022 · 24 co-filers$500.0MVersant Vantage III, L.P.Oct 2022 · 24 co-filers$250.0MVersant Voyageurs III, L.P.Oct 2022 · 25 co-filers$250.0MMarch Therapeutics, Inc.Sep 2022 · 5 co-filers$30.3MMarch Therapeutics, Inc.Sep 2022 · 5 co-filers$30.3MMarket Wagon, Inc.Aug 2022 · 11 co-filers$4.0MLycia Therapeutics, Inc.Sep 2021 · 11 co-filers$70.1MLycia Therapeutics, Inc.Sep 2021 · 11 co-filers$70.1MSaber Equity Diversification Fund LLCAug 2021 · 2 co-filers$15.0MMarket Wagon, Inc.Aug 2021 · 10 co-filers$5.0MSaber Equity Diversification Fund LLCJul 2021 · 4 co-filers$15.0M858 Therapeutics, Inc.May 2021 · 12 co-filers$40.0MOBSIDIAN FUND LLCApr 2021 · 5 co-filersVersant Venture Capital VIII, L.P.Apr 2021 · 23 co-filers$560.2MVersant Vantage II, L.P.Apr 2021 · 23 co-filers$253.9M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Clare in the interactive graph →